- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 325.34M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $41.3M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $41.06M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $86.24M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $70.67M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $339.91M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $330.15M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $528.7M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $563.97M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $447.99M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $428.03M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $982.93M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $951.87M |
| Net Income | Q1 2025 · Mar 31, 2025 | $61.79M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$24.83M |
| Revenue | Q1 2025 · Mar 31, 2025 | $116.49M |
| Revenue | Q1 2025 · Mar 31, 2024 | $81.35M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $73.01M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $39.45M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 315.37M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $10.24M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $2.03M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $546.15M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $564.19M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $23.79M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $11.49M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$23.12M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $17.23M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $64.13M |